Evidence map›Paper›PMID 20729910›Full record

ArticleOncogene2010

ALDH1L1 inhibits cell motility via dephosphorylation of cofilin by PP1 and PP2A.

N V Oleinik, N I Krupenko, S A Krupenko

Abstract read
In one paragraph

Article in Oncogene, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cofilin(s) and Mitochondria: Function Beyond Actin Dynamics.International journal of molecular sciences · 2025
    Review
  7. ALDH1L2 drives HCC progression through TAM polarization.JHEP reports : innovation in hepatology · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. microPublication biology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

N V OleinikDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
N I Krupenko
S A Krupenko
Medical University of South Carolina · US

Funding

MECHANISM OF ACTIONS OF A MAJOR FOLATE ENZYMER01DK054388 · NIDDK · VANDERBILT UNIVERSITY · PI KRUPENKO, SERGEY A · 1998 to 2015
$4.7M
FDH: A Novel Determinant of Tumor SuppressionR01CA095030 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KRUPENKO, SERGEY A · 2005 to 2014
$2.5M
NCI NIH HHS CA095030NCI NIH HHS R01 CA095030NIDDK NIH HHS DK054388NIDDK NIH HHS R01 DK054388
6 · The paper itself

Abstract

Here we report that ALDH1L1 (FDH, a folate enzyme with tumor suppressor-like properties) inhibits cell motility. The underlying mechanism involves F-actin stabilization, re-distribution of cytoplasmic actin toward strong preponderance of filamentous actin and formation of actin stress fibers. A549 cells expressing FDH showed a much slower recovery of green fluorescent protein-actin fluorescence in a fluorescence recovery after photobleaching assay, as well as an increase in G-actin polymerization and a decrease in F-actin depolymerization rates in pyren-actin fluorescence assays indicating the inhibition of actin dynamics. These effects were associated with robust dephosphorylation of the actin depolymerizing factor cofilin by PP1 and PP2A serine/threonine protein phosphatases, but not the cofilin-specific phosphatases slingshot and chronophin. In fact, the PP1/PP2A inhibitor calyculin prevented cofilin dephosphorylation and restored motility. Inhibition of FDH-induced apoptosis by the Jun N-terminal kinase inhibitor SP600125 or the pan-caspase inhibitor zVAD-fmk did not restore motility or levels of phosphor-cofilin, indicating that the observed effects are independent of FDH function in apoptosis. Interestingly, cofilin small interfering RNA or expression of phosphorylation-deficient S3A cofilin mutant resulted in a decrease of G-actin and the actin stress fiber formation, the effects seen upon FDH expression. In contrast, the expression of S3D mutant, mimicking constitutive phosphorylation, prevented these effects further supporting the cofilin-dependent mechanism. Dephosphorylation of cofilin and inhibition of motility in response to FDH can also be prevented by the increased folate in media. Furthermore, folate depletion itself, in the absence of FDH, resulted in cofilin dephosphorylation and inhibition of motility in several cell lines. Our experiments showed that these effects were folate specific and not a general response to nutrient starvation. Overall, this study shows the presence of distinct intracellular signaling pathways regulating motility in response to folate status and points toward mechanisms involving folates in promoting a malignant phenotype.

Indexed as

Cell MovementActinsAldehyde DehydrogenaseCell Line, TumorCofilin 1CytosolDietary SupplementsEnzyme InhibitorsFolic AcidFolic Acid DeficiencyFormyltetrahydrofolate DehydrogenaseGene Expression Regulation, EnzymologicHumansMutationNeoplasm InvasivenessOxidoreductases Acting on CH-NH Group DonorsActinsAldehyde DehydrogenaseCofilin 1Enzyme InhibitorsFolic AcidFormyltetrahydrofolate DehydrogenaseOxidoreductases Acting on CH-NH Group DonorsProtein Phosphatase 1Protein Phosphatase 2

Identifiers

PMID20729910
PMCPMC2992098
OpenAlexW2012859385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.